Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatment SECTIONS Last Updated: May 05, 2021, 08:04 PM IST Share Synopsis The antibody cocktail is to be administered for the treatment of mild to moderate coronavirus disease in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-COV2 and who are at high risk of developing severe COVID-19 disease, the statement said. PTI Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards...